114 related articles for article (PubMed ID: 10328704)
1. Treatment of acute myeloid leukemia.
Gorin NC; Labopin M
N Engl J Med; 1999 May; 340(18):1437; author reply 1438. PubMed ID: 10328704
[No Abstract] [Full Text] [Related]
2. Treatment of acute myeloid leukemia.
Suzuki R; Seto M; Morishima Y
N Engl J Med; 1999 May; 340(18):1436-7; author reply 1438. PubMed ID: 10328703
[No Abstract] [Full Text] [Related]
3. Transplantation in first remission of acute myeloid leukemia.
Burnett AK
N Engl J Med; 1998 Dec; 339(23):1698-700. PubMed ID: 9834309
[No Abstract] [Full Text] [Related]
4. Remission induction chemotherapy induces in vivo caspase-dependent apoptosis in bone marrow acute myeloid leukemia blast cells and spares lymphocytes.
Vial JP; Tabrizi R; Pigneux A; Lacombe F; Praloran V; Belloc F
Cytometry B Clin Cytom; 2006 May; 70(3):115-23. PubMed ID: 16572429
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute myeloid leukemia.
Woods WG; Sanders JE; Neudorf S
N Engl J Med; 1999 May; 340(18):1437-9. PubMed ID: 10328705
[No Abstract] [Full Text] [Related]
6. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
7. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
8. Maintenance therapy in childhood acute myeloid leukemia.
Perel Y; Auvrignon A; Leblanc T; Michel G; Vannier JP; Dalle JH; Gandemer V; Schmitt C; Mèchinaud F; Lamagnere JP; Piguet Ch; Couillaud G; Pautard B; Baruchel A; Leverger G; ;
Ann Hematol; 2004; 83 Suppl 1():S116-9. PubMed ID: 15124700
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acute myeloid leukemia.
Kanda Y; Miwa A; Togawa A
N Engl J Med; 1999 May; 340(18):1436; author reply 1438. PubMed ID: 10328701
[No Abstract] [Full Text] [Related]
10. Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia.
Li Q; Kopecky KJ; Mohan A; Willman CL; Appelbaum FR; Weick JK; Issa JP
Clin Cancer Res; 1999 May; 5(5):1077-84. PubMed ID: 10353741
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of early response to induction therapy as assessed by multiparameter flow cytometry in acute myeloid leukemia.
Kern W; Voskova D; Schoch C; Schnittger S; Hiddemann W; Haferlach T
Haematologica; 2004 May; 89(5):528-40. PubMed ID: 15136215
[TBL] [Abstract][Full Text] [Related]
12. Genetics in the management of adult de novo AML.
Bloomfield CD
Clin Adv Hematol Oncol; 2003 Nov; 1(11):640, 645-6. PubMed ID: 16258460
[No Abstract] [Full Text] [Related]
13. 5'-(3')-nucleotidase mRNA levels in blast cells are a prognostic factor in acute myeloid leukemia patients treated with cytarabine.
Galmarini CM; Cros E; Graham K; Thomas X; Mackey JR; Dumontet C
Haematologica; 2004 May; 89(5):617-9. PubMed ID: 15136231
[TBL] [Abstract][Full Text] [Related]
14. [What was the cause of fever, neck pain and arm paresis? Normal blood picture led to error].
Stiefelhagen P
MMW Fortschr Med; 2005 Nov; 147(45):19. PubMed ID: 16320648
[No Abstract] [Full Text] [Related]
15. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
[TBL] [Abstract][Full Text] [Related]
16. Adult patients with t(8;21) acute myeloid leukemia had no superior treatment outcome to those without t(8;21): a single institution's experience.
Lee KW; Choi IS; Roh EY; Kim DY; Yun T; Lee DS; Yoon SS; Park S; Kim BK; Kim NK
Ann Hematol; 2004 Apr; 83(4):218-24. PubMed ID: 14628154
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol.
Oriol A; Ribera JM; Esteve J; Guàrdia R; Brunet S; Bueno J; Pedro C; Llorente A; Tormo M; Besalduch J; Sánchez JM; Batlle M; Vivancos P; Carreras E; Vilà JM; Julià A; Sierra J; Montserrat E; Feliu E;
Haematologica; 2004 Jul; 89(7):791-800. PubMed ID: 15257930
[TBL] [Abstract][Full Text] [Related]
18. Emerging treatments in acute myeloid leukaemia.
Kell J
Expert Opin Emerg Drugs; 2004 May; 9(1):55-71. PubMed ID: 15155136
[TBL] [Abstract][Full Text] [Related]
19. Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia.
Altundag O; Altundag K; Celik I; Turker A; Kars A
Am J Hematol; 2004 Apr; 75(4):263-4. PubMed ID: 15054828
[No Abstract] [Full Text] [Related]
20. The role of autologous transplantation for acute myeloid leukemia in first and second remission.
Linker C
Best Pract Res Clin Haematol; 2007 Mar; 20(1):77-84. PubMed ID: 17336257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
